TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD

Teva Pharmaceutical Industries Limited

5 Basel Street
Petach Tikva 4951033
Israel
972 3 914 8171
http://www.tevapharm.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees51,792

Key Executives

NameTitlePayExercisedYear Born
Mr. Kåre SchultzPres, Chief Exec. Officer & DirectorN/AN/A1961
Mr. Michael McClellanExec. VP & CFON/AN/A1971
Mr. Mark SabagExec. VP of Global HRN/AN/A1971
Dr. Carlo de NotaristefaniExec. VP of Global Operations1.94MN/A1958
Dr. Hafrun FridriksdottirExec. VP of Global R&DN/AN/A1962
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

Corporate Governance

Teva Pharmaceutical Industries Limited’s ISS Governance QualityScore as of August 1, 2018 is 5. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.